Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin / 한국유방암학회지
Journal of Breast Cancer
; : 141-148, 2019.
Article
en En
| WPRIM
| ID: wpr-738408
Biblioteca responsable:
WPRO
ABSTRACT
The luteinizing hormone-releasing hormone/androgen receptor (LHRH/AR) pathway is a promising treatment target in a subgroup of female patients with triple-negative breast cancer (TNBC). However, very little is known about the efficacy of this strategy in male patients with TNBC. In this report, we describe a male patient with AR-positive TNBC who was successfully treated using an LHRH agonist after pretreatment with several lines of chemotherapy and achieved a durable response. We also review the existing evidence supporting LHRH- and AR-targeted therapy for this rare disease.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Luteína
/
Receptores Androgénicos
/
Hormona Liberadora de Gonadotropina
/
Goserelina
/
Neoplasias de la Mama Masculina
/
Enfermedades Raras
/
Quimioterapia
/
Neoplasias de la Mama Triple Negativas
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Journal of Breast Cancer
Año:
2019
Tipo del documento:
Article